The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Helsinn Birex Pharmaceuticals LimitedPA0294/018/003

Main Information

Trade NameAULIN
Active SubstancesNIMESULIDE
Dosage FormGel
Licence HolderHelsinn Birex Pharmaceuticals Limited
Licence NumberPA0294/018/003

Group Information

ATC CodeM02AX10 various


License statusWithdrawn
Withdrawn Date04/11/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back